ATE262896T1 - Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern - Google Patents

Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Info

Publication number
ATE262896T1
ATE262896T1 AT98928504T AT98928504T ATE262896T1 AT E262896 T1 ATE262896 T1 AT E262896T1 AT 98928504 T AT98928504 T AT 98928504T AT 98928504 T AT98928504 T AT 98928504T AT E262896 T1 ATE262896 T1 AT E262896T1
Authority
AT
Austria
Prior art keywords
vitamin
ldl
oxidation
lycopine
prevent
Prior art date
Application number
AT98928504T
Other languages
English (en)
Inventor
Bianca Fuhrman
Michael Aviram
Zohar Nir
Morris Zelkha
Original Assignee
Lycored Natural Prod Ind Ltd
Bianca Fuhrman
Michael Aviram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12111297A external-priority patent/IL121112A/xx
Priority claimed from IL12493098A external-priority patent/IL124930A0/xx
Application filed by Lycored Natural Prod Ind Ltd, Bianca Fuhrman, Michael Aviram filed Critical Lycored Natural Prod Ind Ltd
Application granted granted Critical
Publication of ATE262896T1 publication Critical patent/ATE262896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98928504T 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern ATE262896T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12111297A IL121112A (en) 1997-06-19 1997-06-19 Synergistic pharmaceutical or dietary compositionscomprising lycopene and vitamin e for preventing ldl oxidation
IL12493098A IL124930A0 (en) 1998-06-16 1998-06-16 Natural compositions for the prevention of ldl oxidation
PCT/IL1998/000286 WO1998057622A1 (en) 1997-06-19 1998-06-18 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation

Publications (1)

Publication Number Publication Date
ATE262896T1 true ATE262896T1 (de) 2004-04-15

Family

ID=26323453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928504T ATE262896T1 (de) 1997-06-19 1998-06-18 Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern

Country Status (8)

Country Link
EP (1) EP0996431B1 (de)
JP (1) JP2002504928A (de)
AT (1) ATE262896T1 (de)
AU (1) AU8031998A (de)
DE (1) DE69822834T2 (de)
DK (1) DK0996431T3 (de)
ES (1) ES2218833T3 (de)
WO (1) WO1998057622A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2261416T3 (es) 2000-05-25 2006-11-16 Boehringer Ingelheim International Gmbh Metodo para mejorar la proteccion celular que comprende un antioxidante lipofilico y un antioxidante hidrofilico.
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids for the preparation of substances for the treatment of high blood pressure
IL141039A (en) * 2001-01-23 2006-10-31 Lycored Natural Prod Ind Ltd The composition for the prevention of atherosclerosis containing carotenoids and use for the preparation of drugs to inhibit LDL oxidation
ATE436020T1 (de) * 2001-08-22 2009-07-15 Cambridge Theranostics Ltd Diagnose und behandlung von atherosklerose
US7504226B2 (en) 2001-08-22 2009-03-17 Cambridge Theranostics Ltd. Methods relating to treatment of atherosclerosis
JP4818637B2 (ja) * 2005-05-02 2011-11-16 日本メナード化粧品株式会社 低密度リポタンパク質（ｌｄｌ）酸化抑制剤
JP5798717B2 (ja) * 2007-10-25 2015-10-21 ニュートリー株式会社 血中の糖、マロンジアルデヒド修飾ｌｄｌ、ホモシステイン及び／又はｃ反応性タンパク質を低減するための組成物
EP2952104A1 (de) 2014-06-05 2015-12-09 Böhm, Kirsten Zusammensetzung und Verfahren zur Vermeidung von Beschädigungen von menschlichen Zellen durch ionisierende Strahlung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2126679C1 (ru) * 1990-10-01 1999-02-27 Бригхэм энд Уименз Хоспитал Способ ингибирования и профилактики возникновения сосудистых явлений бета-каротином и витамином е, фармацевтическая композиция, состоящая из бета-каротина и витамина е, фармацевтическая композиция, состоящая из бета-каротина и аспирина
WO1995035099A1 (en) * 1994-06-20 1995-12-28 Kv Pharmaceutical Company Vitamin/nutrient dosage regimentation
AU705467C (en) * 1994-12-22 2002-12-19 Cognis Corporation Pharmaceutical compositions comprising lycopene
JPH10511355A (ja) * 1994-12-22 1998-11-04 ヘンケル コーポレーション トコフェロールとベータ−カロチンの組成物

Also Published As

Publication number Publication date
AU8031998A (en) 1999-01-04
DE69822834D1 (de) 2004-05-06
ES2218833T3 (es) 2004-11-16
JP2002504928A (ja) 2002-02-12
EP0996431B1 (de) 2004-03-31
EP0996431A1 (de) 2000-05-03
DE69822834T2 (de) 2005-03-24
DK0996431T3 (da) 2004-04-26
WO1998057622A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
BR9908222A (pt) Composições para regular a aparência da pele
BG98933A (en) Cooled and atomized nabumetone
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AU6408298A (en) Essential oil composition
HUT77778A (hu) Meghatározott részecskeméretű modafinilt tartalmazó gyógyszerkészítmény
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
BR0108478A (pt) Formulação nutritiva contendo substancias pré-bióticas
DE59409568D1 (de) Wirkstoffe und gas enthaltende mikropartikel
WO2002034072A3 (en) Synergistic antioxidant combination of delta tocols and polyphenols
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
BR9813083A (pt) Composições à base de extratos de vegetais
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
ATE262896T1 (de) Synergistische zusammensetzungen von lycopin und vitamin e, die der oxidation der ldl verhindern
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
BR9907770A (pt) Mistura sinérgica de produtos naturais e seu uso
ES2126772T3 (es) Composiciones hipocolesterolemicas dieteticas que comprenden proteinas de soja y sitosteroles.
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
MY120958A (en) Use of a flavonoid extract of ginkgo biloba leaves, and more specifically of a terpene-free extract, in the pharmaceutical and/or cosmetic domain and more particularly in the buccodental domain
MD970269A (en) Clavulanates
DE68905973D1 (de) Synergistische suessungsmittel-zusammensetzungen, enthaltend chlorodeoxysucrase, und diese enthaltende zusammensetzungen.
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
WO1998057622B1 (en) Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties